Kevin W. Hunt

804 citations

18 papers · 575 indexed · h-index 10

Co-authors: K. C. Nicolaou Remo Kranich Juan A. Vega Phil S. Baran Yong‐Li Zhong Sofía Barluenga Ege T. Kavalali E. D. Nosyreva
Topics: Computational Drug Discovery Methods (5 papers)Drug Transport and Resistance Mechanisms (3 papers)Alzheimer's disease research and treatments (3 papers)
Cited by: Biological Psychiatry Organic Chemistry Pharmacology
Journals: Nature Journal of the American Chemical Society Angewandte Chemie International Edition
Partner nations: United States Switzerland South Korea

In The Last Decade

Kevin W. Hunt

18 papers receiving 567 citations

Peers

Countries citing papers authored by Kevin W. Hunt

Since Specialization

Citations

This map shows the geographic impact of Kevin W. Hunt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin W. Hunt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin W. Hunt more than expected).

Fields of papers citing papers by Kevin W. Hunt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kevin W. Hunt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin W. Hunt. The network helps show where Kevin W. Hunt may publish in the future.

Co-authorship network of co-authors of Kevin W. Hunt

This figure shows the co-authorship network connecting the top 25 collaborators of Kevin W. Hunt. A scholar is included among the top collaborators of Kevin W. Hunt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin W. Hunt. Kevin W. Hunt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	Effects of a ketamine metabolite on synaptic NMDAR function 2017 ·Nature ·Kanzo Suzuki,E. D. Nosyreva,Kevin W. Hunt,Ege T. Kavalali,Lisa M. Monteggia	134
2	Mitigation of opioid off-target effects and identification of structural drivers of opioid receptor engagement for BACE-1 small molecule inhibitors. 2015 ·PubMed ·Dolores Diaz,Donna M. Dambach,Michael Siu,Kevin W. Hunt,Allen A. Thomas,Joseph P. Lyssikatos,Xingrong Liu,(unknown),(unknown),Kevin A. Ford	2
3	Synthesis, characterization, and PK/PD studies of a series of spirocyclic pyranochromene BACE1 inhibitors 2014 ·Bioorganic & Medicinal Chemistry Letters ·Matthew Volgraf,Lina Chan,Malcolm P. Huestis,Hans E. Purkey,Michael Burkard,Mary Geck,J. Ieuan Harris,Kevin W. Hunt,Xingrong Liu,Joseph P. Lyssikatos,Sumeet Rana,Allen A. Thomas,Guy Vigers,Michael Siu	9
4	Dose-dependent exposure and metabolism of GNE-892, a β-secretase inhibitor, in monkeys: contributions by P450, AO, and P-gp 2014 ·European Journal of Drug Metabolism and Pharmacokinetics ·Ryan Takahashi,Shuguang Ma,Qin Yue,(unknown),Yijun Yi,Joseph P. Lyssikatos,Kelly Regal,Kevin W. Hunt,Nicholas C. Kallan,Michael Siu,Cornelis E. C. A. Hop,Xingrong Liu,S. Cyrus Khojasteh	2
5	Elucidating the Mechanism of Cytochrome P450–Mediated Pyrimidine Ring Conversion to Pyrazole Metabolites with the BACE1 Inhibitor GNE-892 in Rats 2014 ·Drug Metabolism and Disposition ·Ryan Takahashi,Shuguang Ma,Alan Deese,Qin Yue,(unknown),Yijun Yi,Michael Siu,Kevin W. Hunt,Nicholas C. Kallan,Cornelis E. C. A. Hop,Xingrong Liu,S. Cyrus Khojasteh	9
6	Mechanistic Pharmacokinetic-Pharmacodynamic Modeling of BACE1 Inhibition in Monkeys: Development of a Predictive Model for Amyloid Precursor Protein Processing 2013 ·Drug Metabolism and Disposition ·Xingrong Liu,Harvey Wong,Kimberly Scearce‐Levie,Ryan J. Watts,Melis Coraggio,Young G. Shin,Kun Peng,Kristin R. Wildsmith,Jasvinder K. Atwal,(unknown),Stephen Schauer,Kelly Regal,Kevin W. Hunt,Allen A. Thomas,Michael Siu,Joseph P. Lyssikatos,Gauri Deshmukh,Cornelis E. C. A. Hop	17
7	Qualification and application of a liquid chromatography–tandem mass spectrometric method for the determination of human Aβ1-40 and Aβ1-42 peptides in transgenic mouse plasma using micro-elution solid phase extraction 2013 ·Archives of Pharmacal Research ·Young G. Shin,L. Lee Hamm,(unknown),(unknown),Michael H. Buonarati,April Cox,Kelly Regal,Kevin W. Hunt,Kimberly Scearce‐Levie,Ryan J. Watts,(unknown)	5
8	Diethylaminosulfur trifluoride-mediated intramolecular cyclization of 2-hydroxycycloalkylureas to fused bicyclic aminooxazoline compounds and evaluation of their biochemical activity against β-secretase-1 (BACE-1) 2013 ·Tetrahedron Letters ·Malcolm P. Huestis,Wendy Liu,Matthew Volgraf,Hans E. Purkey,Christine Yu,Weiru Wang,Darin Smith,Guy Vigers,Darrin Dutcher,Kevin W. Hunt,Michael Siu	3
9	Selective Synthesis of 1-Functionalized-alkyl-1H-indazoles 2009 ·Organic Letters ·Kevin W. Hunt,(unknown),(unknown),(unknown),(unknown)	46
10	Model Studies Towards Azadirachtin: Part 1. Construction of the Crowded C8bC14 Bond by Radical Chemistry We thank Drs. D. H. Huang and G. Siuzdak for NMR spectroscopic and mass spectrometric assistance, respectively. This work was financially supported by the National Institutes of Health (USA), the Skaggs Institute for Chemical Biology, postdoctoral fellowships from Bayer AG (to M.F.) and the G. E. Hewitt Foundation (to K.W.H.), a predoctoral fellowship from the Division of Organic Chemistry of the American Chemical Society sponsored by Novartis (to A.J.R.), and grants from Abbott Laboratories, ArrayBiopharma, Bayer, Boehringer Ingelheim, DuPont, Glaxo, Hoffmann-LaRoche, Merck, Novartis, Pfizer, and Schering Plough. 2002 ·Angewandte Chemie International Edition ·K. C. Nicolaou,(unknown),A. J. Roecker,Kevin W. Hunt	39
11	Iodine(V) Reagents in Organic Synthesis. Part 3. New Routes to Heterocyclic Compounds via o-Iodoxybenzoic Acid-Mediated Cyclizations: Generality, Scope, and Mechanism 2002 ·Journal of the American Chemical Society ·K. C. Nicolaou,Phil S. Baran,Yong‐Li Zhong,Sofía Barluenga,Kevin W. Hunt,Remo Kranich,Juan A. Vega	236
12	Model Studies Towards Azadirachtin: Part 1. Construction of the Crowded C8bC14 Bond by Radical Chemistry We thank Drs. D. H. Huang and G. Siuzdak for NMR spectroscopic and mass spectrometric assistance, respectively. This work was financially supported by the National Institutes of Health (USA), the Skaggs Institute for Chemical Biology, postdoctoral fellowships from Bayer AG (to M.F.) and the G. E. Hewitt Foundation (to K.W.H.), a predoctoral fellowship from the Division of Organic Chemistry of the American Chemical Society sponsored by Novartis (to A.J.R.), and grants from Abbott Laboratories, ArrayBiopharma, Bayer, Boehringer Ingelheim, DuPont, Glaxo, Hoffmann-LaRoche, Merck, Novartis, Pfizer, and Schering Plough. 2002 ·Angewandte Chemie ·K. C. Nicolaou,(unknown),A. J. Roecker,Kevin W. Hunt	18
13	Oxabicyclo[3.2.1]octenes in Organic Synthesis: Direct Ring Opening of Oxabicyclo[3.2.1] Ring Systems with Diisobutylaluminum Hydride and a Silyl Ketene AcetalSynthesis of the Chiral C(19)−C(26) and C(27)−C(32) Fragments of Scytophycin C 2002 ·Organic Letters ·Kevin W. Hunt,Paul A. Grieco	19
14	ChemInform Abstract: Oxabicyclo[3.2.1]octenes in Organic Synthesis—Direct Ring Opening of Oxabicyclo[3.2.1] Systems Employing Silyl Ketene Acetals in Concentrated Solution of Lithium Perchlorate—Diethyl Ether: Application to the Synthesis of the C(19)—C(27) Fragment of Rifamycin S. 2001 ·ChemInform ·Kevin W. Hunt,Paul A. Grieco	1
15	Oxabicyclo[3.2.1]octenes in Organic SynthesisDirect Ring Opening of Oxabicyclo[3.2.1] Systems Employing Silyl Ketene Acetals in Concentrated Solutions of Lithium Perchlorate−Diethyl Ether: Application to the Synthesis of the C(19)−C(27) Fragment of Rifamycin S 2001 ·Organic Letters ·Kevin W. Hunt,Paul A. Grieco	21
16	Baeyer−Villiger Oxidation Promoted by Reaction of Peracids with Cyclic Oxocarbenium Ions Generated in Situ from Internal Hemiketals 2000 ·Organic Letters ·Kevin W. Hunt,Paul A. Grieco	4
17	Baeyer−Villiger Oxidation Promoted by Reaction of Peracids with Cyclic Oxocarbenium Ions Generated in Situ from Internal Hemiketals 2000 ·Organic Letters ·Kevin W. Hunt,Paul A. Grieco	9
18	Extractives of Australian timbers. IX. The saponin of Planchonella pohlmanianum 1969 ·Australian Journal of Chemistry ·(unknown),Kevin W. Hunt,JJH Simes,William Stern	1

About Kevin W. Hunt

Kevin W. Hunt is a scholar working on Biochemistry, Computational Theory and Mathematics and Organic Chemistry, having authored 18 papers that have together received 575 indexed citations. Recurring topics across this work include Computational Drug Discovery Methods (5 papers), Drug Transport and Resistance Mechanisms (3 papers) and Alzheimer's disease research and treatments (3 papers). The work is most often cited by research in Biological Psychiatry (89 citations), Organic Chemistry (359 citations) and Pharmacology (162 citations). Kevin W. Hunt has collaborated with scholars based in United States, Switzerland and South Korea. Frequent co-authors include K. C. Nicolaou, Remo Kranich, Juan A. Vega, Phil S. Baran, Yong‐Li Zhong, Sofía Barluenga, Ege T. Kavalali, E. D. Nosyreva, Lisa M. Monteggia and Paul A. Grieco. Their work appears in journals such as Nature, Journal of the American Chemical Society and Angewandte Chemie International Edition.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact